Desarrollo clínico del edoxabán. Estudios en fase II

Weitz, 2010, Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation, Thromb Haemost, 104, 633, 10.1160/TH10-01-0066 Yamashita, 2012, Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with nonvalvular atrial fibrillation, Circ J, 76, 1840, 10.1253/circj.CJ-11-1140 Ruff, 2010, Am Heart J, 160, 635, 10.1016/j.ahj.2010.06.042 Salazar, 2012, Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation, Thromb Haemost, 107, 925, 10.1160/TH11-08-0566